Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial von Jacobson, Caron A, Chavez, Julio C, Sehgal, Alison R, William, Basem M, Munoz, Javier, Salles, Gilles, Munshi, Pashna N, Casulo, Carla, Maloney, David G, de Vos, Sven, Reshef, Ran, Leslie, Lori A, Yakoub-Agha, Ibrahim, Oluwole, Olalekan O, Fung, Henry Chi Hang, Rosenblatt, Joseph, Rossi, John M, Goyal, Lovely, Plaks, Vicki, Yang, Yin, Vezan, Remus, Avanzi, Mauro P, Neelapu, Sattva S

Volltext

Anti-spike antibody response to the COVID vaccine in lymphoma patients von Della Pia, Alexandra, Kim, Gee Youn Geeny, Ip, Andrew, Ahn, Jaeil, Liu, Yanzhi, Kats, Simone, Koropsak, Michael, Lukasik, Brittany, Contractor, Anamta, Amin, Krushna, Ayyagari, Lakshmi, Zhao, Charles, Gupta, Amolika, Batistick, Mark, Leslie, Lori A, Goy, Andre H, Feldman, Tatyana A

Volltext

Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma von Benjamini, Ohad, Fried, Shalev, Shouval, Roni, Flynn, Jessica R, Beyar-Katz, Ofrat, Leslie, Lori A, Zucherman, Tsilla, Yerushalmi, Ronit, Shem-Tov, Noga, Palomba, Maria Lia, Danylesko, Ivetta, Sdayoor, Inbal, Malka, Hila, Itzhaki, Orit, Suh, Hyung, Devlin, Sean M, Marcus, Ronit, Dahi, Parastoo B, Jacoby, Elad, Shah, Gunjan L, Sauter, Craig S, Ip, Andrew, Perales, Miguel-Angel, Nagler, Arnon, Shimoni, Avichai, Scordo, Michael, Avigdor, Abraham

Volltext

Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas von Leslie, Lori A.

Volltext

Phase 1b Dose‐finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B‐cell Lymphoma von Petrillo, Alessandra, Ip, Andrew, Della Pia, Alexandra, Gill, Sarvainder, Zenreich, Joshua, Gutierrez, Martin, McNeill, Ann, Feldman, Tatyana, Leslie, Lori A., Goy, Andre

Volltext

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma von Westin, Jason R., Oluwole, Olalekan O., Kersten, Marie José, Miklos, David B., Perales, Miguel-Angel, Ghobadi, Armin, Rapoport, Aaron P., Sureda, Anna, Jacobson, Caron A., Farooq, Umar, van Meerten, Tom, Ulrickson, Matthew, Elsawy, Mahmoud, Leslie, Lori A., Chaganti, Sridhar, Dickinson, Michael, Dorritie, Kathleen, Reagan, Patrick M., McGuirk, Joseph, Song, Kevin W., Riedell, Peter A., Minnema, Monique C., Yang, Yin, Vardhanabhuti, Saran, Filosto, Simone, Cheng, Paul, Shahani, Shilpa A., Schupp, Marco, To, Christina, Locke, Frederick L.

Volltext

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia von Roeker, Lindsey E., Knorr, David A., Pessin, Melissa S., Ramanathan, Lakshmi V., Thompson, Meghan C., Leslie, Lori A., Zelenetz, Andrew D., Mato, Anthony R.

Volltext

A Rare Case of Grey Zone Lymphoma Successfully Treated with Brentuximab Vedotin and R-CHP Chemotherapy von Leslie, Lori A., Shenoy, Vishnu A., Alquran, Lance, Mallipudi, Rajiv M., Conti, John A.

Volltext

Clinical use of emerging therapies in relapsed or refractory follicular lymphoma von Leslie, Lori A

Volltext

Umbralisib, a Dual PI3K delta/CK1 epsilon Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma von Fowler, Nathan H., Samaniego, Felipe, Jurczak, Wojciech, Ghosh, Nilanjan, Derenzini, Enrico, Reeves, James A., Knopinska-Posluszny, Wanda, Cheah, Chan Y., Phillips, Tycel, Lech-Maranda, Ewa, Cheson, Bruce D., Caimi, Paolo F., Grosicki, Sebastian, Leslie, Lori A., Chavez, Julio C., Fonseca, Gustavo, Babu, Sunil, Hodson, Daniel J., Shao, Spencer H., Burke, John M., Sharman, Jeff P., Law, Jennie Y., Pagel, John M., Miskin, Hari P., Sportelli, Peter, O'Connor, Owen A., Weiss, Michael S., Zinzani, Pier Luigi

Volltext

Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status von Huang, Qing, Deering, Kathleen L., Harshaw, Qing, Leslie, Lori A.

Volltext

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma von Locke, Frederick L., Miklos, David B., Jacobson, Caron A., Perales, Miguel-Angel, Kersten, Marie-José, Oluwole, Olalekan O., Ghobadi, Armin, Rapoport, Aaron P., McGuirk, Joseph, Pagel, John M., Muñoz, Javier, Farooq, Umar, van Meerten, Tom, Reagan, Patrick M., Sureda, Anna, Flinn, Ian W., Vandenberghe, Peter, Song, Kevin W., Dickinson, Michael, Minnema, Monique C., Riedell, Peter A., Leslie, Lori A., Chaganti, Sridhar, Yang, Yin, Filosto, Simone, Shah, Jina, Schupp, Marco, To, Christina, Cheng, Paul, Gordon, Leo I., Westin, Jason R.

Volltext

Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach von Roeker, Lindsey E, Feldman, Tatyana A, Soumerai, Jacob D, Falco, Victoria, Panton, Gail, Dorsey, Colleen, Zelenetz, Andrew D, Falchi, Lorenzo, Park, Jae H, Straus, David J, Pena Velasquez, Camila, Lebowitz, Sonia, Fox, Yehudit, Battiato, Kristen, Laudati, Carissa, Thompson, Meghan C, McCarthy, Elizabeth, Kdiry, Sabrina, Martignetti, Rosalba, Turpuseema, Teja, Purdom, Michelle, Paskalis, Dana, Miskin, Hari P, Sportelli, Peter, Leslie, Lori A, Mato, Anthony R

Volltext

Refining the management of relapsed or refractory follicular lymphoma: case scenarios von Pagel, John M, Burke, John M, Leslie, Lori A

Volltext

Outcomes in patients with aggressive B‐cell non‐Hodgkin lymphoma after intensive frontline treatment failure von Ayers, Emily C., Li, Shaoying, Medeiros, L. Jeffrey, Bond, David A., Maddocks, Kami J., Torka, Pallawi, Mier Hicks, Angel, Curry, Madeira, Wagner‐Johnston, Nina D., Karmali, Reem, Behdad, Amir, Fakhri, Bita, Kahl, Brad S., Churnetski, Michael C., Cohen, Jonathon B., Reddy, Nishitha M., Modi, Dipenkumar, Ramchandren, Radhakrishnan, Howlett, Christina, Leslie, Lori A., Cytryn, Samuel, Diefenbach, Catherine S., Faramand, Rawan, Chavez, Julio C., Olszewski, Adam J., Liu, Yang, Barta, Stefan K., Mukhija, Dhruvika, Hill, Brian T., Ma, Helen, Amengual, Jennifer E., Nathan, Sunita, Assouline, Sarit E., Orellana‐Noia, Victor M., Portell, Craig A., Chandar, Ashwin, David, Kevin A., Giri, Anshu, Hess, Brian T., Landsburg, Daniel J.

Volltext

Refining the management of relapsed or refractory follicular lymphoma von Pagel, John M, Burke, John M, Leslie, Lori A

Volltext

Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study von Zayac, Adam S., Evens, Andrew M., Danilov, Alexey, Smith, Stephen D., Jagadeesh, Deepa, Leslie, Lori A., Wei, Catherine, Kim, Seo-Hyun, Naik, Seema, Sundaram, Suchitra, Reddy, Nishitha, Farooq, Umar, Kenkre, Vaishalee P., Epperla, Narendranath, Blum, Kristie A., Khan, Nadia, Singh, Daulath, Alderuccio, Juan P., Godara, Amandeep, Yazdy, Maryam Sarraf, Diefenbach, Catherine, Rabinovich, Emma, Varma, Gaurav, Karmali, Reem, Shao, Yusra, Trabolsi, Asaad, Burkart, Madelyn, Martin, Peter, Stettner, Sarah, Chauhan, Ayushi, Choi, Yun Kyong, Straker-Edwards, Allandria, Klein, Andreas, Churnetski, Michael C., Boughan, Kirsten M., Berg, Stephanie, Haverkos, Bradley M., Orellana-Noia, Victor M., D'Angelo, Christopher, Bond, David A., Maliske, Seth M., Vaca, Ryan, Magarelli, Gabriella, Sperling, Amy, Gordon, Max J., David, Kevin A., Savani, Malvi, Caimi, Paolo, Kamdar, Manali, Lunning, Matthew A., Palmisiano, Neil, Venugopal, Parameswaran, Portell, Craig A., Bachanova, Veronika, Phillips, Tycel, Lossos, Izidore S., Olszewski, Adam J.

Volltext

Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination Era von Della Pia, Alexandra, Zhao, Charles, Jandir, Parul, Gupta, Amolika, Batistick, Mark, Kim, Gee Youn (Geeny), Xia, Yi, Ahn, Jaeil, Magarelli, Gabriella, Lukasik, Brittany, Leslie, Lori A, Goy, Andre H, Ip, Andrew, Feldman, Tatyana A

Volltext

Long-Term Survival and Absence of Late Relapses in Patients Who Underwent Allogeneic Stem Cell Transplantation for Advanced Cutaneous T-Cell Lymphoma von Leslie, Lori A, Feldman, Tatyana A, Skarbnik, Alan P, Vesole, David H., Rowley, Scott D., Pecora, Andrew L., Goy, Andre, Donato, Michele L.

Volltext

High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor... von Skarbnik, Alan P, DiLorenzo, Mary E, Andrews, Tracy, McKiernan, Phyllis, Rowley, Scott D., Vesole, David H., Goy, Andre, Feldman, Tatyana, Leslie, Lori A, Pecora, Andrew L., Donato, Michele L.

Volltext